IntegraGen Logo

IntegraGen

Genomic analysis & molecular diagnostics for cancer and rare diseases for researchers and labs.

ALINT | PA

Overview

Corporate Details

ISIN(s):
FR0010908723
LEI:
969500CQD8K0BUIGDH55
Country:
France
Address:
5 RUE HENRI DESBRUERES, 91000 EVRY-COURCOURONNES
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

IntegraGen, an OncoDNA group company, specializes in the genomics of cancer and rare genetic diseases. The company's mission is to translate molecular research into clinical practice through the development and commercialization of molecular diagnostic tests derived from the identification of genetic biomarkers. It provides expert genomic analysis and interpretable data services to academic researchers, private laboratories, and other life sciences organizations, aiming to advance both research and patient care.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-29 17:45
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 352.0 KB
2025-10-06 18:30
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 238.4 KB
2025-04-29 18:00
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 351.8 KB
2025-04-29 18:00
Earnings Release
Inside Information / News release on accounts, results
English 356.4 KB
2025-01-15 18:44
Earnings Release
Inside Information / Information on annual revenues
English 214.4 KB
2025-01-15 18:44
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
French 215.6 KB
2024-10-17 18:29
Earnings Release
Inside Information / News release on accounts, results
English 343.2 KB
2024-10-17 18:29
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 398.7 KB
2024-07-18 18:44
Earnings Release
Inside Information / Other news releases
English 270.7 KB
2024-07-18 18:44
Earnings Release
Informations privilégiées / Autres communiqués
French 268.3 KB
2024-04-18 18:00
Earnings Release
Inside Information / News release on accounts, results
English 372.7 KB
2024-04-18 18:00
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 419.4 KB
2024-01-16 17:45
Earnings Release
Inside Information / Information on annual revenues
English 307.9 KB
2024-01-16 17:45
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
French 269.3 KB
2023-10-19 18:15
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 332.6 KB

Automate Your Workflow. Get a real-time feed of all IntegraGen filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IntegraGen

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IntegraGen via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Developing nanomedicines and drug delivery systems for oncology, hematology, and diagnostics.
Malaysia N/A
A holding company driving regional growth by supporting construction, HR, and nursing care businesses.
Japan 7369
Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden IMMU
Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America M3D
MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan 9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan 9227
MindWalk Holdings Corp. Logo
AI-powered biotherapeutics firm offering end-to-end antibody discovery and engineering services.
United States of America HYFT
Minerva Neurosciences, Inc. Logo
A clinical-stage biopharma developing treatments for central nervous system (CNS) diseases.
United States of America NERV
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan 3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan 4883

Talk to a Data Expert

Have a question? We'll get back to you promptly.